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A b s t r a c t s  9 
Documentation in the Medical Laboratory' (INSTAND) and under 
the auspices of three scientific societies (DVV, GN, DGHM). 
Lyophilized plasmas positive for HIV-1, HCV or HBV, or lyophilized 
debris of cells infected with one of the herpes viruses, are prepared 
in large quantities for external and internal quality controls. 
Results and conclusions: Shortly after a given EQAS, these 
EQAS camples are available for daily internal quality control of 
routine diagnostics as well as evaluation and standardization of new 
tests by laboratories, companies, and authorities (e.g. Paul Ehrlich 
Institute). O n  the basis of these materials, national working references 
were prepared for qualitative and quantitative detection of HCV 
(genotype lb;  30 000 and 3000 geq/mL) and HIV-1 (subtype B; 
40 000 and 4000 geq/mL). The regular participation at the EQASs 
and the use of EQAS samples and national working references have 
been proven to raise the rate of correct quantitative HIV-1 detection 
from 85% to 98%. 
/s25] Outcome analysis 
A. von Graevenitz. Department vf Medical Microbiology, University o j  
Zurirb, Zurich, Switzerland 
Laboratory resources have been strained by costs of new tests, salaries 
of personnel, equipment, etc. More and more, a laboratory is 
required to justify certain expenses, and even its existence. A tool for 
the evaluation of a laboratory's purpose and performance is outcome 
analysis. Possible kinds of outcome refer to the laboratory itself (e.g. 
staffing, turnaround time of testing, cost of supplies and equipment), 
patient care (e.g. length of hospital stay, mortality, various costs) or  
the reputation of the laboratory (e.g. physician satisfaction). 
To assess the consequences and cost of changes, a program called 
BASICC (Basic Assessment Scheme for Intervention Costs and 
Consequences) may be used and has at its endpoint 'net cost', defined 
as cost of program plus cox of side effects minus cost of outcome 
averted (see M M W R  1995; 44/RR(10): 1-10). This formula pre- 
supposes knowledge of patient care costs per defined diagnosis, and 
of the cost and outcome without the planned changes. Outcome 
analysis may be applied to the use of certain tests (e.g. antigen testing, 
broth enrichments, smears), communication channels (e.g. order 
forms) or statistics. Examples will be provided. 
Intestinal protozoa and echinococcosis 
ms27) Cyclospora and microsporidia: clinical and 
diagnostic aspects 
R. Weber. Ittfirtiotrz Diseases, University Hospital, Zurich, Switzerland 
Cyclospora rayctanensis, previously termed blue-green alga, 
cyanobacteriuni-like body, or coccidia-like body, was recently 
characterized as belonging to the coccidians. It has been identified 
worldwide in stool speciniens of iinniunocompetent and iinmuno- 
coinproniised patients. The spectrum of illness is not yet fully defined 
but it may range from asymptomatic carriage of the organism to 
severe and prolonged diarrhea in immunocompetent and immuno- 
compromised patients. Prevalence data have yet to be assessed. The 
parasite is transmitted by the fecal-oral route and infection is most 
probably acquired from contaminated water or food. Diagnosis is 
dependent on light microscopic detection of the oocysts. Controlled 
trials showed that cotrimoxazole was clinically successful and 
shortened oocyst shedding. 
Microsporidia are obligate intracellular, spore-forming protozoa. 
Seven genera (Entcroryfozoon, Encephnbforoori, Nuscrira, Bracbiola, 
Krtaforma, Pleistophora, Trackiplrictophora) and unclassified niicro- 
sporidia can infect humans. The sources of niicrosporidia and modes 
of transmission are uncertain. Microsporidiosis occurs primarily in 
persons infected with HIV, but it is also emerging in otherwise 
immunocompromised hosts and in iminunocompetent individuals. 
The most robust technique for diagnosis of microsporidiosis is the 
light microscopic detection of the parasites. Species identification is 
made using electron microscopy, antigenic analy$is, or molecular 
analysis. The clinical manifestations include intestinal, ocular, nius- 
cular, cerebral, respiratory and urinary tract disease. Treatment with 
albeiidazole can result in cure of encephalitozoonosis. No therapy is 
available for enterocytozoon infection. An improvement of immune 
function following highly active antiretroviral treatment may lead to 
parasite clearance in infected persons with AIDS. 
I S28 I Host tissue destruction by Entamoeba 
histolytica 
E. Tannich. Bemhard Nocbt Inst., Molerrilar Parasitolqy, Hatnburg, 
Gevmariy 
The protozoan parasite Entamoeba histolytica is characterized by its 
extraordinary capacity to destroy human tissues, leading to massive 
and sometimes lethal pathologic alterations such as ulcerative colitis 
or abscesses of various organs, most conimonly of the liver. Recent 
studies have indicated that at least three functions of the amoebae are 
important for pathogenic tissue invasion. Pathogenicity ic viewed as 
the result mainly of (1) adherence of the amoebae to host cells, 
predominantly mediated by a galactose- and N-acetylgalactosaniine- 
inhibitable surface lectin, (2) killing of host cells by pore-forming 
peptides known 3s amoebapores, and (3) proteolysis of the host's 
extracellular matrix mediated by cycteine proteinases. Structural 
detailed molecular analysis including cloning of the corresponding 
genes from E. histolytica and from the non-pathogenic species E.  
dispar have led to a better understanding of the function of these 
proteins. 
Immune responses in alveolar echinococcosis 
B. Gottstein. Iirstiti~te (f Parasitology, Utiiuersity of Brrnc, Berne, 
Switzerland 
Infection with E.  ntuftilocularis encounters either constitutional resist- 
ance, late resistance or full susceptibility to alveolar echinococcosis 
(AE). Dissection of humoral, cell-mediated and cytokine-mediated 
immune responses in susceptible and resistant humans showed 
differences partially dependent on host M H C  class I1 polymorphism. 
Thus progressive AE was associated with D R 3  and DQ2, whereas 
D R l  1 was associated with improved AE prognosis. DR1 3 was m o s  
frequent in cured AE patients. A niuriiie AE model (C57BL/6) 
allowed uc to document a marked initnunosuppression phenomenon 
characterized by significantly suppressed splenocyte proliferative 
responses to ConA and to Emc antigen. Conversely, splenic cytokine 
production (IL-2, IL-4, and IFN-gamma) remained non-suppressed. 
Infection in mice resulted in strong Mac-1 cell infiltration of the 
peritoneal cavity and spleen. Corresponding PEC from infected mice 
expressed significantly higher levels of inflammatory cytokine 
transcripts for IL-1, TNF-alpha and iNOS than that from non- 
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infected control mice, but IL-10 transcript levels remained low. 
Supplementation of spleen cells with PEC from infected mice 
resulted in a markedly increased nitrite level in response to ConA and 
Emc antigen, and also complete suppression of splenic proliferation. 
The spleen cells from late-stage p i .  exhibited strongly increased 
iNOS levels when compared to normal splenocytes, correlating with 
the immunosuppression demonstrated at late stages of AE. The 
suppressed splenic responses were reversible by the addition of 
NMMA. Taken together, these facts contribute to our understanding 
of how the parasite can develop in certain patients suffering &om AE 
and how in other infected individuals the parasite dies out without 
causing disease. 
m] Actual developments in clinical diagnosis and 
treatment of echinococcosis 
Z.S.  Pawlowski. University of Medical Srietzces, Poznan, Poland 
The objectives were to review problems of clinical diagnosis in 
relation to the natural history of Echinotoccus granulosus and E. 
multilotuularis and to present rules of optimal treatment of echino- 
coccosis in the individual cases. 
There are four stages of the most common hepatic E .  granulosus 
infections: an early, invasive stage (serologic implications, no clinical 
expression), sterile cyst (differentiation with simple non-parasitic 
cysts), fertile cysts (easiest to be diagnosed by imaging) and 
degenerating cysts (differentiation with non-parasitic hyperdense or 
calcified space-occupying lesions). E. multilocularis infection, when 
suspected by imaging, has to be confirmed by serology (Em-2 and 
Em-18 tests). In both echinococcoses the diagnostic process should 
end in defining species, number, location and stage of the parasite(s). 
The choice of optimal treatment in echinococcosis must be 
individualized according to the parasite, the patient and the doctor‘s 
specific experience (cases of E .  multilocularis infection must be treated 
only in a specialized center). In cystic echinococcosis there are four 
methods of treatment: surgery (no longer the only choice), PAIR 
(puncture, aspiration, injection of an anthelmintic and reaspiration), 
chemotherapy (curative or preventive) and the ‘wait and observe’ 
approach (in inactive or degenerating cysts). In alveolar echino- 
coccosis radical surgery (if possible) and long-term chemotherapy 
with albendazole provides the only chance of survival. 
Genome analysis and infectious diseases 
m] The bacterium Mycoplasma pneumoniae 
as a model for a minimal self-replicating 
cell 
R. Herrmann, H. Gohlmann, J. Regula, B. Uberle, J. Weiner, 
E. Pirkl. Universitiit Heideulberx, Zewtnrmf: Molekidare Bioloyie, 
Heidelbex, Germany 
Mycoplasinas are bacteria of special evolutionary interest because of 
their small genomes, lack of cell walls and parasitic lifestyles. They 
evolved according to a widely accepted hypothesis by degenerative 
evolution from more complex Gram-positive bacteria. We have 
chosen Mycoplusma pneumoniae as a model organism for studying the 
‘biology’ of a small, self-replicating cell. Mycoplasma prieumoniae is a 
surface parasite of the human respiratory tract and causes primary 
atypical pneumonia, preferentially in children and young adults. The 
bacterial pathomechanisms are only poorly understood. To learn 
more about the biochemistry, physiology and molecular genetics of 
Mycoplasma pneumoniae and to understand complex events like 
differential gene expression or interaction between individual cell 
components, we applied the improved methods of DNA sequencing, 
computer-aided data processing and simultaneously monitoring large 
numbers of different inRNA species and proteins. First, the complete 
nucleotide sequence of the Mycoplasma pneumoniae genome was 
established (816 394 base pairs) and about 50% of the 677 proposed 
genes (open reading frames, ORFs) were functionally assigned by 
their significant similarity to genes with known function &om other 
organisms. Presently, we focus on the gene expression analysis at the 
cellular level, including all the transcripts (transcriptome) and proteins 
(proteome) which are synthesized in Mycoplasma pneumoniae under 
standard growth conditions (37”C, rich medium). These standard 
transcription and translation profiles will be compared to profiles 
derived from Mycoplasma pneumoniae grown under modified con- 
ditions, like changes in temperature or in concentrations of salt or 
oxygen. The differences in profiles should provide information about 
genes that are of particular importance for growth under the corres- 
ponding conditions. A summary of the results from these combined 
experimental approaches will be given. 
ml Rickettsia (obligate intracellular parasites) 
S.G.E. Anderson, A. Zomorodipour, J. Anderson, T. Sicheritz, 
C. Alsmark, K. Naslund, A.-S. Eriksson, C. Kurland. Uppsala 
University, Dept. of Molecular Biology, Uppsala, Sweden 
We have sequenced the 1.1-Mb genome of Rickettsia prownzekii, an 
obligate intracellular parasite and the causative agent of epidemic, 
louse-borne typhus in humans. R. prowazekii is estimated to have 
infected tens of millions of people in armies, ghettos and prison 
camps during the First and Second World Wars. In spite of its 
fearsome reputation, we have found that the genome is highly 
degenerate and seems to gradually be losing genes it once needed to 
function. The bioenergetic repertoire of R. prowazekii is consistent 
with the hypothesis that mitochondria and rickettsia share a common 
ancestor. Phylogenetic reconstructions based on genes encoding 
components of the tricarboxylic acid cycle as well as of the electron 
transport system provide strong evidence to suggest that the 
bioenergetic system in mitochondria has originated &om an ancestor 
of the rickettsia. A comparative genome analysis of the obligate 
intracellular parasites R. prowazekii and Chlamydia trachomatis has 
yielded examples of reductive convergent evolution, including the 
loss of genes involved in the biosynthesis of metabolites such as amino 
acids, nucleotides and S-adenosylmethionine. Examples of novel 
gene functions that have evolved in response to transitions to intra- 
cellular growth environments are adenine nucleotide translocators, 
which facilitate the exploitation of cytoplasmic ATP as a source of 
energy. Comparative studies of genes subjected to mutational 
meltdown in a variety of Rickettsia species have revealed mechanisms 
whereby genes disappear and genomes decay. These results are 
discussed in terms of reductive evolutionary processes which 
in the long term may drive obligate intracellular parasites to 
extinction. 
